Established in Sweden, 1995 Recipharm has since grown to become a leading Contract Development and Manufacturing Organization (CDMO), Recipharm employs approximately 3,500 professionals. Recipharm focus is pharmaceutical companies support by bringing products from early development to commercial manufacturing, throughout the entire product lifecycle utilizing innovative solutions and providing value for money to our clients. Recipharm Israel is managed by Dr. Sylvia Kachalsky and Gideon Silberman. Our local team of highly skilled chemists with extensive equipment available in Ness Ziona together with the team in Sweden, is the best choice for any chemistry related development.
Ephraim Abramson & Co.
Ephraim Abramson & Co. is one of the leading law firms in Israel with a dynamic and diversified practice, which encompasses nearly all areas of domestic and international commercial representation. Ephraim Abramson & Co. has significant experience with complex transactional work of substantial scope, both in Israel and abroad, and the full range of day-to-day representation of its clients in a wide range of industries including start-up and mature private and publicly-traded corporations, venture capitalists, individual entrepreneurs, major non-profit and government-related institutions, and Israeli government ministries and agencies.
Boston Scientific mission is to transform lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is dedicated to collaborating with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, increase efficiencies and—most importantly—help more people in more places around the world live longer, healthier lives.
BioStats Ltd., a leading boutique biostatistics consulting firm has been fulfilling the needs of the biomedical industry for over 15 years. Combining deep knowledge of bio-statistics with unparalleled industry expertise, we are responsible for a rich list of successful regulatory submissions (US, Europe, Asia) of medical devices and biologics. Via our core biostatistics and data management business, our highly experienced bio-statisticians, who are committed to providing excellent service, will add value as they accompany you through the entire process from the pre-clinical stage through regulatory submission.
CellCure Neurosciences Ltd.
Cell Cure Neurosciences is a biotechnology company owned by BioTime, Teva Pharmaceutical Industries and Hadasit Bio-Holdings is focused on developing cell based therapies for retinal and neural degenerative disease. Our first developed product, OpRegen®, is aimed to treat Age-Related Macular Degeneration, based on human embryonic stem cells (hESC), which, for the first time in the history of medicine, open the door to industrial-scale manufacture of any cell type in the human body.
JMB Davis Ben-David is on the doorstep of Europe and in the hub of the Start-Up Nation, an IP boutique specializing in intellectual property rights in the United States and Israel. We have a unique combination of outstanding academic and professional qualifications from US, UK and Israel institutions and our proven abilities over almost 20 years, made us the US and Israel Patent and Trademark Attorneys of choice for many local companies and universities, as well as world players in the fields of healthcare, computer technologies, luxury items, electric devices and footwear.
YuanMing Capital is a healthcare specialty fund focusing on China-US cross border investments with offices in Beijing and New York City. The investment team has rich industry experience and a successful investment track record. The fund invests in therapeutics, medical devices, diagnostics as well as healthcare service companies based in US and/or China. We seek to bring capital and strategic resources to the future leaders of the industry. Contact: David Li: davidli at ymfunds.com +972-54-8786861
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Its flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics around the world – allowing type 2 patients to begin insulin therapy without fear of needles. Oramed’s oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes.
Terralab Ventures is dedicated to finding and growing the technologies and innovation that will make tomorrow that much brighter. We believe in the power of entrepreneurship, technology and operational excellence. We harness this power each day by investing in and growing game changing ventures that have the potential to influence millions of lives and positively impact the world. Our team works closely with entrepreneurs to jumpstart ideas and achieve business objectives. We aren’t just there to finance, we want to get our hands dirty with you and really make things happen.
Valera Health was founded on the belief that effective behavioral health management is key to overall wellbeing. We are passionate about creating personalized and preventive behavioral health solutions that are scalable, innovative, and effective. We ground our solutions in evidence-based models and innovate with cutting-edge digital technology and data analytics. Our team draws from decades of experience implementing integrated care in clinical practice, and working in behavioral health, data analytics, healthcare policy, pharmaceuticals, venture capital, startups and academia.
HIL Applied Medical
HIL Applied Medical is developing a new class of ultra-compact, high-performance cancer Proton Therapy systems, which combines nanotechnology, high-intensity lasers and ultra-fast magnets – paving the way for truly cost-effective, expandable, add-on, single-room solutions.
Androphin Medical is developing a tearable non recoiling catheter which prevents harm that may be caused when the intentional or accidental pulling of urological catheter occurs. The device also facilitates the medical treatment and replacement of the catheter when needed.
Pepticom Ltd. was founded in 2011 to revolutionize the discovery of novel peptide drug candidates using its key asset, an exceptional artificial intelligence platform aimed at designing peptide ligands based upon solved crystal structures which enables Pepticom to operates in various disciplines and generate innovative binding peptides for diverse targets.
Tetrax FB poses an innovative, highly effective diagnostic System for the detection of subtle Neuro-Physiological disorders and Neuro-Anatomic Disturbances based on human posture analysis.
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require for accurate personalized therapy based on comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive tumor’s progression.
Semorex develops and commercializes innovative and novel targeted therapeutics utilizing our Selective Molecular Recognition technology for cancer patients.
TenCure is set to transform the field of Oncology therapeutics by developing a new class of targeted personalized treatments for skin, pancreatic and colon cancer, based on inhibition of Diabetes induced genes.
Imagine Bio advises global life sciences companies and clinical stage start-ups on strategy, partnerships, and investments. We work with industry and investors to identify and close targeted deals with innovative pharma, medical device, biotech, diagnostic, and digital health companies. Our start-up practice advises clinical stage startups on successful business strategies, professional branding, and effective messaging in their presentations, websites, and marketing materials to attract investment and strategic partners.